Page last updated: 2024-08-23

nitazoxanide and Encephalitis, JC Polyomavirus

nitazoxanide has been researched along with Encephalitis, JC Polyomavirus in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	5 (83.33)	2.80

Authors

Authors	Studies
Chisari, CG; Finocchiaro, C; Lo Fermo, S; Millefiorini, E; Patti, F; Sgarlata, E; Toscano, S	1
Anand, B; Annadure, RK; Arulselvan, V; Deepalam, S; Gupta, S; Ichaporia, N; Iyer, RB; John, SK; Kamath, V; Kumar, S; Mathew, T; Murgod, U; Nadig, R; Nair, SS; Neeharika, ML; Netravathi, M; Parry, G; Raghavendra, S; Reddy, YM; Renukaradhya, U; Rohatgi, A; Sarma, GRK; Satishchandra, P; Sharath Kumar, GG; Shivakumar, R; Singh, P; Singhal, BS; Surya, N; Yareeda, S	1
Arroyo-Pereiro, P; Bau, L; León, I; Martínez-Yélamos, A; Martínez-Yélamos, S; Matas, E; Muñoz-Vendrell, A; Romero-Pinel, L	1
Bava, CI; Bertolotto, A; Capobianco, M; Di Sapio, A; Malentacchi, M; Malucchi, S; Martire, S; Oggero, A; Sperli, F; Valentino, P	1
Boccia, VD; Cellerino, M; Inglese, M; Lapucci, C; Mikulska, M; Sirito, T; Sticchi, L	1
Bode, MK; Glumoff, V; Hägg, PM; Hautala, NM; Hautala, TJ; Murk, JL; Perelygina, L; Renko, MH; Rusanen, HT; Schneider-Hohendorf, T; Schwab, N; Seppänen, MRJ; Sullivan, KE; Vuorinen, T	1

Trials

1 trial(s) available for nitazoxanide and Encephalitis, JC Polyomavirus

Article	Year
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment. Journal of neurology, 2023, Volume: 270, Issue:5 Topics: Humans; Immunologic Factors; JC Virus; Leukoencephalopathy, Progressive Multifocal; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Risk Assessment	2023

Other Studies

5 other study(ies) available for nitazoxanide and Encephalitis, JC Polyomavirus

Article	Year
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies. Current neuropharmacology, 2022, Volume: 20, Issue:10 Topics: Adult; Female; Humans; Immunologic Factors; JC Virus; Leukoencephalopathy, Progressive Multifocal; Longitudinal Studies; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Nitro Compounds; Thiazoles	2022
A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosis. Multiple sclerosis and related disorders, 2022, Volume: 66 Topics: Adolescent; Adult; Female; Humans; Immunologic Factors; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Nitro Compounds; Thiazoles	2022
Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. Multiple sclerosis and related disorders, 2023, Volume: 77 Topics: Biomarkers; Humans; Intermediate Filaments; Leukoencephalopathy, Progressive Multifocal; Multiple Sclerosis; Natalizumab; Retrospective Studies	2023
Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series. Multiple sclerosis (Houndmills, Basingstoke, England), 2023, Volume: 29, Issue:11-12 Topics: Humans; Immunologic Factors; Leukoencephalopathy, Progressive Multifocal; Multiple Sclerosis; Natalizumab; Vaccination	2023
Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy. Journal of clinical immunology, 2018, Volume: 38, Issue:1 Topics: Adolescent; Adult; Antiparasitic Agents; Antiviral Agents; Brain; Epilepsy; Female; Humans; Immunologic Deficiency Syndromes; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Nitro Compounds; Polyomavirus; Polyomavirus Infections; Skin; Thiazoles	2018